FdaApplication
ANDA 206674
Identifiers
- fda_app_no: ANDA206674
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2016-02-09 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE;ORAL |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 200MG | TABLET, EXTENDED RELEASE;ORAL |
3 products